Sign in
4

Changes in Ownership

Arcutis Biotherapeutics, Inc. Filed Acc 0001628280-26-074807

Director sold 4,728 shares at $28.16 ($133,140)

  • Director acquired 4,094 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Welgus Howard G. · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2026-11-16 Exercise or conversion : show line 1 in the form 10b5-1 +822 $6.52 $5,361 36,029 D
2026-11-16 Exercise or conversion : show line 2 in the form 10b5-1 +1,018 $7.51 $7,645 37,047 D
2026-11-16 Exercise or conversion : show line 3 in the form 10b5-1 +2,254 $8.63 $19,452 39,301 D
2026-11-16 Sale : show line 4 in the form 10b5-1 −4,728 $28.16 $133,140 34,573 D
Open-market sales · 4,728 sh · avg $28.16 · $133,140

Table II: Derivative

3 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2026-11-16 Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (right to buy) −822 $6.52 2029-11-20 822 4,930 D
2026-11-16 Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (right to buy) −1,018 $7.51 2033-05-31 1,018 6,108 D
2026-11-16 Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (right to buy) −2,254 $8.63 2034-06-14 2,254 13,524 D
Loading xslF345X06/wk-form4_1795036412.xml…